Almagel Plus

Quick links to important sections

Almagel Plus

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Almagel Plus

What is Almagel Plus?

Almagel Plus is a combined pharmaceutical formulation used to manage symptoms associated with increased gastric acidity and excessive intestinal gas. It belongs to a class of medications known as antacids and antiflatulents. The product is typically presented as an oral suspension, which allows for uniform distribution of the active components along the mucosal lining of the digestive tract.

Composition and Mechanism of Action

The effectiveness of Almagel Plus is derived from the synergistic action of its primary active ingredients:

  • Aluminum Hydroxide and Magnesium Hydroxide: These components act as local antacids. They work by neutralizing the hydrochloric acid present in the stomach, which helps to reduce the acidity of gastric juice. This neutralization process aids in protecting the stomach lining from the irritating effects of acid.
  • Simethicone: This is an antiflatulent agent. It functions by changing the surface tension of gas bubbles within the stomach and intestines, causing them to break down or coalesce. This process facilitates the natural elimination of gas, helping to relieve sensations of bloating and pressure.

General Characteristics

Almagel Plus is designed to provide symptomatic relief by acting locally within the gastrointestinal tract. Unlike systemic medications, its primary components are largely not absorbed into the bloodstream, focusing their action on the gastric environment. By neutralizing acid and reducing gas volume, the formulation addresses the physical discomfort associated with various gastric conditions without interfering with the primary production of acid itself.

What side effects are possible with Almagel Plus?

Adverse Reactions and General Safety Profile

Side effects associated with Almagel Plus, a combination of aluminum hydroxide, magnesium hydroxide, and simethicone, primarily involve the gastrointestinal system. Common, but usually non-serious, reactions include diarrhea, constipation, nausea, and vomiting. The effect on stool consistency can vary, with some patients experiencing either diarrhea or constipation. Stool may also appear white in color.

Serious Adverse Reactions and Systemic Risks

Serious adverse effects are typically linked to high doses or prolonged use, especially in individuals with impaired kidney function. These systemic risks include:

  • Hypophosphatemia: The aluminum component can bind phosphate in the gut, leading to low phosphate levels in the blood, which may result in muscle weakness or loss of appetite with chronic use.
  • Hypermagnesemia/Hyperaluminemia: In patients with renal impairment, the body cannot adequately clear magnesium and aluminum, increasing the risk of toxicity. Severe hypermagnesemia can lead to confusion, muscle weakness, and cardiac effects. Aluminum accumulation has been associated with more serious complications like osteomalacia and encephalopathy with chronic, high-dose exposure.
  • Hypersensitivity: Rare, but serious, allergic reactions such as anaphylaxis or angioedema are possible.

Safety Restrictions and Drug Interactions

Use is generally restricted to short periods (e.g., no more than two weeks at maximum dosage) unless directed by a health professional. The product is generally contraindicated or requires particular caution in patients with severe renal impairment due to the risks of electrolyte and mineral accumulation.

Almagel Plus can significantly interact with many oral prescription medications, including certain antibiotics (tetracyclines, quinolones), digoxin, and iron supplements, by reducing their absorption. Therefore, regulatory guidelines advise staggering the administration of this product by at least two hours before or after taking other oral medications.

Overdose and Emergency Response

Overdose and when to seek help

Domain Official Regulatory Statement
Documented Overdose Presentations Acute presentations include diarrhoea, abdominal pain, and vomiting. Systemic effects can involve signs of hypermagnesaemia, such as drowsiness, confusion, muscle weakness, and hypotension.
Emergency-response Statements Treatment for severe magnesium toxicity may require specific procedures, including forced diuresis and the administration of Intravenous Calcium Gluconate.
When immediate medical help is required It is mandated to seek immediate medical attention or contact a Poison Control Center right away if an overdose is suspected.

Overdose Classifications

Classification Official Regulatory Statement
Severity Classification The range includes acute gastrointestinal effects escalating to potentially life-threatening systemic toxicity, such as cardiac arrest.
Population-specific Overdose Notes The risk of severe complications, including intestinal obstruction and chronic outcomes like encephalopathy, is increased in patients with renal impairment and the elderly.

Resulting Overdose Structure

Official overdose statements:

  • A severe overdose can lead to hypermagnesaemia and serious systemic effects, including respiratory depression and cardiac arrhythmias.
  • Large doses pose a documented risk of intestinal obstruction or ileus, especially in patients with pre-existing risk factors.
  • Management procedures, such as haemodialysis or peritoneal dialysis, are required in cases where renal function deficiency complicates the overdose.

Connection to the overall overdose profile: Regulatory documents define the overdose profile by listing acute symptoms alongside the critical need for seeking urgent medical attention due to the potential for systemic and life-threatening complications. The profile emphasizes that the most serious chronic outcomes are officially linked to high-dose exposure in individuals with impaired renal function, thereby focusing the required emergency response on these specific risks and procedural interventions.

Therapeutic Uses of Almagel Plus

Quick Facts

  • May be utilized for managing symptoms of acid indigestion and heartburn.
  • Used to address discomfort associated with gas, such as bloating and pressure.
  • Provides temporary relief from symptoms related to excess stomach acid.

Almagel Plus is an over-the-counter medication intended for the temporary relief of digestive symptoms caused by excess stomach acid. It is commonly employed to manage episodes of heartburn and acid indigestion. The product is used to help soothe discomfort and distress in the stomach and gut, which may be associated with various conditions including acid reflux (gastroesophageal reflux) or gastritis.

The medication also contains an ingredient intended to relieve symptoms of excess gas in the digestive tract. This may include sensations of bloating, pressure, or discomfort in the stomach and intestines. Almagel Plus may be a suitable option for the self-management of these common, temporary digestive concerns.

Eligibility and Restrictions for Use

Who Can and Cannot Use Almagel Plus?

Regulatory documents define strict population eligibility rules for Almagel Plus (Aluminum Hydroxide, Magnesium Hydroxide, Simethicone). Eligibility depends on age, organ function, and specific comorbidities, ensuring its use remains within official labeled conditions.


Contraindications and Restrictions

Classification Population/Condition
Absolute Contraindication Patients with known hypersensitivity to any component.
Patients with severe renal impairment or kidney failure.
Patients with hypophosphataemia (low phosphate levels).
Conditional/Restricted Use Children under 12 years of age (use is not established and requires consultation).
Patients who are pregnant or breastfeeding (must consult a health professional).
Patients with certain metabolic conditions, such as hereditary fructose intolerance or those on a magnesium-restricted diet.

Age-Specific Eligibility

The medicine is approved for adults and adolescents 12 years of age and older. Use in older adults requires caution, as regulatory information notes they are at higher risk for complications like intestinal obstruction due to the aluminum and magnesium components.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Almagel Plus is defined by the non-systemic action of its active antacid components, aluminum hydroxide and magnesium hydroxide. The majority of documented interactions are classified as pharmacokinetic interference that occurs locally in the gastrointestinal tract.


Interference with Oral Medication Absorption

Co-administration with numerous oral medicinal products can result in a significant reduction of their systemic exposure due to binding or chelation in the stomach and intestines. This binding hinders the absorption of the co-administered drug. Medicines explicitly listed in regulatory documents as susceptible to this effect include Tetracycline and Quinolone antibiotics, Thyroid hormones (e.g., levothyroxine), Bisphosphonates, and Digoxin.

To mitigate this reduction in bioavailability, official labels require a mandatory separation of administration time. Susceptible oral medications must be taken at least 2 to 4 hours apart from the antacid dose to maintain their expected plasma concentration.


Specific Interaction Constraints

A notable food and substance interaction involves citrate-containing products (including some foods or supplements), which are documented to increase the systemic absorption of the aluminum component. Additionally, a pharmacodynamic interaction may occur with other laxatives due to the additive osmotic effect of the magnesium component.


Population-Specific Risk

Regulatory information notes a critical constraint for individuals with renal impairment. Due to the reduced clearance of both aluminum and magnesium, these patients face an officially documented increased risk of accumulation and systemic toxicity, such as hypermagnesemia.

Mechanism of Action

The action of Almagel Plus is purely local and non-systemic, governed by three distinct mechanistic domains within the gastrointestinal tract.

The Chemical Neutralization domain targets Hydrochloric Acid ( HCl) and the enzyme Pepsin via an immediate acid-base reaction. The hydroxides rapidly consume H^+ ions, which elevates the intragastric pH and simultaneously causes a pH-dependent inactivation of Pepsin. This mechanism leads to a rapid reduction of chemical irritant potential and proteolytic capacity in the upper digestive tract.

The Physical Antifoaming Action is governed by Simethicone, a surfactant that acts solely on the surface tension of trapped gas. By reducing this tension, small bubbles are forced to coalesce into larger gas pockets. This physical alteration facilitates the natural physiological processes of gas elimination and the modification of intraluminal pressure dynamics.

Finally, the Physiological Balance domain promotes local cytoprotection by modulating mucosal secretion of protective mediators like bicarbonate and prostaglandins. Simultaneously, the combination of ingredients provides a neutral net effect on intestinal smooth muscle tone, mitigating the individual component's influence on transit speed.

Dosage and Administration Information

Administration Guidelines

The administration of the oral suspension containing aluminum hydroxide, magnesium hydroxide, and simethicone adheres to precise parameters. These guidelines specify the route, dose, frequency, and preparation required for proper use.


Administration Scope

Instruction Detail
Route of administration Oral administration only.
Dosing schedule The standard dose for adults and adolescents (12 years and older) is 10 mL to 20 mL (2 to 4 teaspoonfuls). The maximum daily intake is 80 mL (16 teaspoonfuls) within a 24-hour period.
Timing in relation to meals Doses are typically scheduled to be taken after meals and at bedtime (up to 20 minutes to one hour post-meal).
Preparation requirements The container of oral suspension must be shaken well immediately prior to measuring a dose.
Age-group administration rules Use in children under 12 years requires consultation with a physician. The normal adult dose is generally appropriate for older adults.
Special procedural conditions For self-management, the maximum dosage should not be used for more than two weeks.

Connection to the Overall Use Protocol

The use protocol is defined by an oral route, with a standardized unit dose taken up to four times per day, structured around mealtimes and bedtime. This regimen establishes the quantitative constraints (maximum daily dose) and temporal boundaries (maximum duration of use) required for the administration of the liquid suspension.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Almagel Plus

Evidence for Symptomatic Relief of Heartburn and Acid Indigestion

The combination medicine was studied for patient-reported outcomes describing perceived discomfort related to acid-related symptoms, such as heartburn and acid indigestion. Research includes short-term randomized controlled trials (RCTs) that focus specifically on the measurement of gastric pH changes in the antacid components. Observational studies have also been applied to examine patient-reported experiences for similar combinations in conditions like symptomatic Gastroesophageal Reflux Disease (GERD). Studies monitored symptom changes and pH levels, with findings describing patterns observed over the very short term.

Evidence for Symptomatic Relief of Flatulence and Bloating

This medicine was evaluated in research exploring outcomes related to functional imbalance, specifically excess gas, bloating, and abdominal pressure. The evidence includes comparative trials and RCTs that examined the antiflatulent component, simethicone. Studies monitored patient-reported outcomes describing perceived discomfort like abdominal fullness and pressure. Findings describe patterns observed over short-term intervals. Evidence is limited in contexts where gas and bloating are the sole primary research outcome, as these symptoms are often assessed as part of a composite symptom score in larger trials.

The Scope of Long-Term Studies and Follow-up

Research exploring short-term symptom changes defines the follow-up durations were limited for this medication, rarely extending beyond two weeks. This means there is limited information for long-term outcomes regarding the repeated or continuous use of this combination product. Long-term effects are not fully established, as research is focused entirely on acute symptomatic relief.

Evidence Gaps and Uncertainties

The evidence landscape is limited by several factors. The evidence quality varies across studies, with some key information relying on research conducted on the individual components rather than the precise three-component combination. Comparative evidence is lacking in certain areas, and data for certain groups remain insufficient, particularly for older adults or children. Research provides context but not individual predictions regarding the continuous use and durability of symptomatic changes.

Frequently Asked Questions (FAQ)

Common questions about Almagel Plus (FAQ)


Q: What is the difference in components between Almagel and Almagel Plus?

A: The main difference is the addition of an active ingredient called Simethicone in the 'Plus' formulation. Simethicone is an anti-gas agent, meaning the Plus formulation is intended to address both stomach acid symptoms and gas/bloating. Both products contain the acid-neutralizing ingredients, Aluminum Hydroxide and Magnesium Hydroxide.


Q: How long does the effect of a single dose of the liquid suspension typically last?

A: Official information describes this medication as providing rapid, short-term relief for digestive symptoms. Because it is an antacid, its main action is the immediate neutralization of existing acid. Antacids generally provide relief for a shorter duration than some other classes of acid-reducing medications.


Q: Is Almagel Plus officially indicated for conditions like gastric ulcers or GERD?

A: Regulatory documents mention that this medicine is used for the symptomatic relief of conditions such as gastroesophageal reflux (GERD) and its related heartburn. It is also described in regulatory contexts for the prevention or treatment of ulcers. Management of these conditions is generally conducted under the supervision of a health professional.


Q: Why does the formulation include both aluminum hydroxide and magnesium hydroxide?

A: The combination of aluminum and magnesium hydroxides is used to balance the drug's overall effect on the digestive system. Aluminum hydroxide can have a constipating effect, while magnesium hydroxide can have a laxative effect. Combining the ingredients is done to achieve a more balanced effect on bowel movements.


Q: How quickly can a person expect to feel symptom relief after taking Almagel Plus?

A: Relief from symptoms is typically expected to be very fast. Because this medicine works by directly neutralizing stomach acid through a rapid chemical reaction, relief is often reported to begin within a few minutes of administration.


Q: Is diarrhea a potential side effect, and why is this mentioned for the product?

A: Diarrhea is listed in official documents as a potential side effect due primarily to the Magnesium Hydroxide component. Magnesium has an osmotic effect, which draws water into the bowel.


Q: Are there warnings about interactions with common vitamins or OTC supplements?

A: Official guidelines recommend consultation with a health professional if any prescription medication is being taken, as antacids are known to interfere with the absorption of many oral drugs. It is generally acknowledged that separating the dose of this medicine from any other oral product, including supplements, is recommended to ensure proper absorption.


Q: How does the mechanism of action differ from a stronger acid reducer like a PPI (e.g., omeprazole)?

A: Almagel Plus is classified as an antacid and works by neutralizing the acid that is already present in your stomach. In contrast, other classes of acid reducers, such as PPIs (Proton Pump Inhibitors), work differently by targeting and blocking the enzyme system in your stomach that is responsible for producing acid in the first place.


Q: What is the main role of the magnesium component in balancing the overall effect?

A: The primary role of the Magnesium Hydroxide component is two-fold: it helps to neutralize stomach acid, and it also functions as a laxative agent. This laxative effect is incorporated into the formulation to help offset the potential for constipation that can be caused by the Aluminum Hydroxide component.


Q: What should be done if symptoms persist after the maximum recommended duration of self-treatment?

A: Official warnings describe that if symptoms of acid indigestion persist or last for more than two weeks, self-treatment cessation is appropriate. Official guidance indicates that professional medical evaluation is recommended. Persistent symptoms may be a sign of a more serious underlying medical condition that requires specific diagnosis and treatment.


Q: Is Almagel Plus specifically mentioned in research for duodenal ulcers?

A: The medicine is generally described for use in the context of treating or preventing ulcers. Clinical trials on similar active components have examined the management of symptoms associated with duodenal ulcers.


Q: Is there a specific taste or texture associated with the Almagel Plus suspension?

A: According to product information, the liquid suspension typically has a specific taste, often described as a peppermint or mint flavor. As an oral suspension, it is formulated with a thick, liquid texture.


Q: Are dizziness or headache known to occur after taking the medicine?

A: Dizziness or headache are not typically listed among the common side effects for this medication. However, the regulatory profiles for this drug class indicate that rare potential effects on the central nervous system (CNS) have been reported, which may include symptoms like dizziness.


Q: Is there a known interaction between the medication and alcohol consumption?

A: Official drug interaction checks usually show no known significant interaction between the medicine's active components and alcohol itself. However, it is generally noted that alcohol consumption may aggravate the underlying symptoms of acid indigestion and heartburn that the medicine is meant to relieve.


Q: Is Almagel Plus safe for people who have a history of inflammatory bowel disease?

A: Individuals with a history of inflammatory bowel disease (IBD) should approach the use of this medicine with caution. Disease interaction profiles associated with the active ingredients indicate that professional consultation is advised for people with IBD prior to use.


Q: Does the product contain ingredients that are relevant for individuals with diabetes?

A: Yes, the product's inactive ingredients usually include sweeteners such as Sorbitol and/or Saccharin Sodium. It is important for individuals monitoring their carbohydrate or sugar intake due to conditions like diabetes to be aware of these inactive components.


Q: Does the presence of phenylalanine require caution for people with phenylketonuria (PKU)?

A: Official drug labeling requires a specific warning for Phenylketonuria (PKU) if the medicine contains a source of phenylalanine (such as aspartame). Individuals with PKU should refer to the inactive ingredient list on the product’s label for verification.


Q: Does Almagel Plus contain any ingredient that may cause dependence or rebound acidity?

A: The active ingredients in this medication are not associated with chemical dependence. While some acid-reducing medications carry a risk of rebound acidity, the regulatory guidance to limit self-treatment to two weeks is established to avoid masking symptoms of a more serious, chronic condition.

How should Almagel Plus be stored and disposed of?

Storage and Disposal of Almagel Plus (Oral Suspension)

The storage and disposal of Almagel Plus must strictly adhere to officially documented conditions to maintain product integrity and safety.


Official Storage Requirements

  • Temperature: Store at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F). The product must be protected from freezing.
  • Container: The container should be kept tightly closed in its original packaging.
  • Child Safety: All medication must be kept out of the sight and reach of children.

Disposal Instructions

  • Unused Product: Dispose of unused or expired Almagel Plus safely and in accordance with all applicable laws and regulations for pharmaceutical waste. Disposal should avoid flushing the product down a toilet or pouring it down a drain unless specifically authorized by local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Almagel Plus found in:

A-Z Index: